The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Mitochondria-Rich Extracellular Vesicles From Autologous Stem Cell–Derived Cardiomyocytes Restore Energetics of Ischemic Myocardium
Open accessAbstract
Background: Mitochondrial dysfunction results in an imbalance between energy supply and demand in a failing heart. An innovative therapy that targets the intracellular bioenergetics directly through mitochondria transfer may be necessary. Objectives: The purpose of this study was to establish a preclinical proof-of-concept that extracellular vesicles (EVs)-mediated transfer of autologous mitochondria and their related energy source enhance cardiac function through restoration of myocardial bioenergetics. Methods: Human-induced pluripotent stem cells (iPSCs)-derived cardiomyocytes (iCMs) were employed. iCMs conditioned-medium were ultracentrifuged to collect mitochondria-rich EVs (M-EVs). Therapeutic effects of M-EVs were investigated using in vivo murine myocardial infarction (MI) model. Results: Electron microscopy revealed healthy-shaped mitochondria inside M-EVs. Confocal microscopy showed that M-EV-derived mitochondria were transferred into the recipient iCMs and fused with their endogenous mitochondrial networks. Treatment with 1.0×108/mL M-EVs significantly restored the intracellular ATP production and improved contractile profiles of hypoxia-injured iCMs as early as 3-hours after treatment. In contrast, isolated mitochondria that contained 300 times more mitochondrial proteins than 1.0×108/mL M-EVs showed no effect after 24-hours. M-EVs contained mitochondrial biogenesis-related mRNAs, including PGC-1α, which upon transfer activated mitochondrial biogenesis in the recipient iCMs at 24-hours after treatment. Finally, intramyocardial injection of 1.0×108 M-EVs demonstrated significantly improved post-MI cardiac function through restoration of bioenergetics and mitochondrial biogenesis. Conclusions: M-EVs facilitated immediate transfer of their mitochondrial and non-mitochondrial cargos, contributing to improved intracellular energetics in vitro. Intramyocardial injection of M-EVs enhanced post-MI cardiac function in vivo. This therapy can be developed as a novel, precision therapeutic for mitochondria-related diseases including heart failure. CONDENSED ABSTRACT: Mitochondrial dysfunction results in an imbalance between energy supply and demand in mitochondria-related diseases, including heart failure (HF). Currently, no therapeutic enhances intracellular energetic supply. The goal of this study is to establish a preclinical proof-of-concept that extracellular vesicles-mediated transfer of autologous mitochondria confers cardioprotection through restoration of cellular bioenergetics. Mitochondria-rich extracellular vesicles (M-EVs) are secreted from induced-pluripotent stem cell-derived cardiomyocytes. Intramyocardial injection of M-EVs facilitate immediate transfer of their mitochondrial and non-mitochondrial cargo into the injured cardiomyocytes, improving cardiac function in mice myocardial infarction model. This novel approach may provide an effective therapeutic for mitochondria-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts
Murry, C. E., Soonpaa, M. H., Reinecke, H., Nakajima, H., Nakajima, H. O., Rubart, M., Pasumarthi, K. B. S., Ismail Virag, J., Bartelmez, S. H., Poppa, V., et al. (2004) · Nature · doi:10.1038/nature02446 · Cited by 2,154
Transfer of mitochondria from astrocytes to neurons after stroke
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., & Lo, E. H. (2016) · Nature · doi:10.1038/nature18928 · Cited by 1,423
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099
Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Yang, X., Pabon, L., & Murry, C. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.300558 · Cited by 939
Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T., Okada, K., Shiba, N., Sakamoto, K., et al. (2016) · Nature · doi:10.1038/nature19815 · Cited by 840
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.
Waagstein, F., Hjalmarson, A., Varnauskas, E., & Wallentin, I. (1975) · Heart · doi:10.1136/hrt.37.10.1022 · Cited by 832
Mitochondrial function as a therapeutic target in heart failure
Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., Voors, A. A., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.203 · Cited by 803
Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Lundy, S. D., Zhu, W.-Z., Regnier, M., & Laflamme, M. A. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0490 · Cited by 738
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M. J., Coffman, R. L., Candia, A., & Mehal, W. Z. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83885 · Cited by 498
Taylor, C. J., Ordóñez-Mena, J. M., Roalfe, A. K., Lay-Flurrie, S., Jones, N. R., Marshall, T., & Hobbs, F. D. R. (2019) · BMJ · doi:10.1136/bmj.l223 · Cited by 495
Beer, M., Seyfarth, T., Sandstede, J., Landschütz, W., Lipke, C., Köstler, H., von Kienlin, M., Harre, K., Hahn, D., & Neubauer, S. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02160-5 · Cited by 387
Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning
de Couto, G., Gallet, R., Cambier, L., Jaghatspanyan, E., Makkar, N., Dawkins, J. F., Berman, B. P., & Marbán, E. (2017) · Circulation · doi:10.1161/circulationaha.116.024590 · Cited by 340
Adamiak, M., Cheng, G., Bobis-Wozowicz, S., Zhao, L., Kedracka-Krok, S., Samanta, A., Karnas, E., Xuan, Y.-T., Skupien-Rabian, B., Chen, X., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311769 · Cited by 335
Puhm, F., Afonyushkin, T., Resch, U., Obermayer, G., Rohde, M., Penz, T., Schuster, M., Wagner, G., Rendeiro, A. F., Melki, I., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314601 · Cited by 306
Kaza, A. K., Wamala, I., Friehs, I., Kuebler, J. D., Rathod, R. H., Berra, I., Ericsson, M., Yao, R., Thedsanamoorthy, J. K., Zurakowski, D., et al. (2017) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.10.077 · Cited by 277
Xu, R., Greening, D. W., Rai, A., Ji, H., & Simpson, R. J. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.008 · Cited by 266
Abnormal Mitochondrial Respiration in Failed Human Myocardium
Sharov, V. G., Todor, A. V., Silverman, N., Goldstein, S., & Sabbah, H. N. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1266 · Cited by 205
Jang, S. C., Crescitelli, R., Cvjetkovic, A., Belgrano, V., Bagge, R. O., Sundfeldt, K., Ochiya, T., Kalluri, R., & Lötvall, J. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1635420 · Cited by 197
Induction of Mitochondrial Biogenesis Is a Maladaptive Mechanism in Mitochondrial Cardiomyopathies
Sebastiani, M., Giordano, C., Nediani, C., Travaglini, C., Borchi, E., Zani, M., Feccia, M., Mancini, M., Petrozza, V., Cossarizza, A., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.035 · Cited by 195
Jung, J.-H., Fu, X., & Yang, P. C. (2017) · Circulation Research · doi:10.1161/circresaha.116.309307 · Cited by 176
Self-citationDelivery of exogenous mitochondria via centrifugation enhances cellular metabolic function
Kim, M. J., Hwang, J. W., Yun, C.-K., Lee, Y., & Choi, Y.-S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21539-y · Cited by 170
Tachibana, A., Santoso, M. R., Mahmoudi, M., Shukla, P., Wang, L., Bennett, M., Goldstone, A. B., Wang, M., Fukushi, M., Ebert, A. D., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310803 · Cited by 169
Self-citationMaintaining Ancient Organelles: Mitochondrial Biogenesis and Maturation
Vega, R. B., Horton, J. L., & Kelly, D. P. (2015) · Circulation Research · doi:10.1161/circresaha.116.305420 · Cited by 156
Mitochondrial transplantation in humans: “magical” cure or cause for concern?
Bertero, E., Maack, C., & O'Rourke, B. P. (2018) · Journal of Clinical Investigation · doi:10.1172/jci124944 · Cited by 123
Human myocardial ATP content and in vivo contractile function
Starling, R. C., Hammer, D. F., & Altschuld, R. A. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5687-9_19 · Cited by 120
Human myocardial ATP content and in vivo contractile function
Starling, R. C., HAMMER, D. F., & Altschuld, R. A. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006876031121 · Cited by 118
Garnier, A., Zoll, J., Fortin, D., N’guessan, B. B., Lefebvre, F., Gény, B., Mettauer, B., Veksler, V., & Ventura‐Clapier, R. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.812099 · Cited by 94
Interspecies mitochondrial fusion between mouse and human mitochondria is rapid and efficient
Yoon, Y. G., Haug, C. L., & Koob, M. D. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.11.022 · Cited by 41
Cited by
Extracellular vesicles as a next-generation drug delivery platform
Herrmann, I. K., Wood, M. J. A., & Fuhrmann, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00931-2 · Cited by 1,948
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,172
The power and potential of mitochondria transfer
Borcherding, N., & Brestoff, J. R. (2023) · Nature · doi:10.1038/s41586-023-06537-z · Cited by 514
Mitochondrial dysfunction in aging
Guo, Y., Guan, T., Shafiq, K., Yu, Q., Jiao, X., Na, D., Li, M., Zhang, G., & Kong, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101955 · Cited by 339
Immune evasion through mitochondrial transfer in the tumour microenvironment
Ikeda, H., Kawase, K., Nishi, T., Watanabe, T., Takenaga, K., Inozume, T., Ishino, T., Aki, S., Lin, J., Kawashima, S., et al. (2025) · Nature · doi:10.1038/s41586-024-08439-0 · Cited by 330
Metadata
- Authors
- Ikeda, G., Santoso, M. R., Tada, Y., Li, A. M., Vaskova, E., Jung, J.-H., O’Brien, C., Egan, E., Ye, J., & Yang, P. C.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 77
- Issue
- 8
- Pages
- 1073-1088
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3129376462
- Cited by
- 298
- References
- 41
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.